Tanaka M, Tanaka K, Idezuka J, Tsuji S
Department of Neurology and Laboratory of Medical Genetics and Immunology, National West Niigata Central Hospital, Niigata 950-21, Japan.
Exp Neurol. 1998 Apr;150(2):337-8. doi: 10.1006/exnr.1997.6760.
Paraneoplastic neurological syndromes are believed to be autoimmune neuronal degenerations that develop in some patients with systemic cancer. Although a high titer of anti-Yo antibody has been found in the sera and cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration (PCD), the role of anti-Yo antibody in Purkinje cell loss has not been shown. Previously we found that all of nine Japanese patients with PCD who harbored anti-Yo antibody had HLA A24. In this present study we have examined cytotoxic T cell (CTL) activity against recombinant Yo protein in peripheral blood of a patient with PCD and anti-Yo antibody using autologous dendritic cells as the target. We did not detect CTL activity against Yo protein, though, this study does not exclude the possibility of the involvement of CTL in the development of PCD.
副肿瘤性神经系统综合征被认为是在一些患有全身性癌症的患者中发生的自身免疫性神经元变性。尽管在副肿瘤性小脑变性(PCD)患者的血清和脑脊液中发现了高滴度的抗Yo抗体,但抗Yo抗体在浦肯野细胞丢失中的作用尚未得到证实。此前我们发现,9名携带抗Yo抗体的日本PCD患者均有HLA A24。在本研究中,我们以自体树突状细胞为靶标,检测了一名患有PCD且有抗Yo抗体的患者外周血中针对重组Yo蛋白的细胞毒性T细胞(CTL)活性。我们未检测到针对Yo蛋白的CTL活性,不过,本研究并不排除CTL参与PCD发病的可能性。